Finance

Lists
Why is BGLC down 6,25%?
Dive Deeper
BGLC:NASDAQ
BioNexus Gene Lab Corp
1,20 $
-6,25%
(-0,080) 1D
6 қаз., 11:12:57 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BGLC...
Open
1,21 $
High
1,24 $
Low
1,20 $
Mkt. cap
3,49 млн
Avg. vol.
6,60 мың
Volume
4,04 мың
52-wk high
5,85 $
52-wk low
1,07 $
EPS
-1,25 $
Beta
-0,94
Shares outstanding
2,93 млн
No. of employees
19
Open
1,21 $
High
1,24 $
Low
1,20 $
Mkt. cap
3,49 млн
Avg. vol.
6,60 мың
Volume
4,04 мың
52-wk high
5,85 $
52-wk low
1,07 $
EPS
-1,25 $
Beta
-0,94
Shares outstanding
2,93 млн
No. of employees
19
News stories
From web sources and news partners
About BioNexus Gene Lab Corp
CEO-
Employees19
Founded2017
Headquarters-
SectorTrading company
Websitebionexusgenelab.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
2,54 млн
483,76 м.
22,84 мың
76,16 мың
Cost of goods sold
2,17 млн
487,74 м.
23,63 мың
63,17 мың
Cost of revenue
2,17 млн
487,74 м.
23,63 мың
63,17 мың
Research and development expenses
14,88 мың
11,10 мың
14,49 мың
13,67 мың
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
997,26 м.
216,74 м.
380,40 м.
334,55 м.
Operating expense
1,15 млн
1,12 млн
562,50 м.
316,61 м.
Total operating expenses
3,31 млн
1,60 млн
586,13 м.
379,78 м.
Operating income
-769,86 м.
-1,12 млн
-563,29 м.
-303,62 м.
Other non operating income
-
1,40 мың
-
-
EBT including unusual items
-708,99 м.
-1,04 млн
-543,58 м.
-286,45 м.
EBT excluding unusual items
-751,37 м.
-1,21 млн
-543,58 м.
-286,45 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-40,41 мың
87,75 мың
-8,15 мың
-8,39 мың
Net income
-708,99 м.
-1,04 млн
-543,58 м.
-286,45 м.
Net profit margin
-27,87%
-214,18%
-2 379,72%
-376,14%
Earnings per share
-
-
-
-
Interest and investment income
24,97 мың
10,13 мың
17,18 мың
21,18 мың
Interest expense
-6,48 мың
-3,27 мың
-3,08 мың
-4,06 мың
Net interest expenses
18,49 мың
6,86 мың
14,09 мың
17,13 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-740,85 м.
-1,09 млн
-534,99 м.
-272,84 м.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары